84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]鄭文偉,何曉娟,賈良良,等.跳骨片含藥血清抑制脂多糖誘導(dǎo)的軟骨細(xì)胞炎癥反應(yīng)的作用機(jī)制研究[J].中醫(yī)正骨,2017,29(08):8-16.
　ZHENG Wenwei,HE Xiaojuan,JIA Liangliang,et al.Study on mechanism of action of Tiaogu Pian(跳骨片)medicated serum in inhibiting inflammatory reaction induced by lipopolysaccharides in chondrocytes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(08):8-16.
點(diǎn)擊復(fù)制

跳骨片含藥血清抑制脂多糖誘導(dǎo)的軟骨細(xì)胞炎癥反應(yīng)的作用機(jī)制研究()
分享到：

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第29卷
期數(shù):
2017年08期
頁(yè)碼:
8-16
欄目:
基礎(chǔ)研究
出版日期:
2017-08-20

文章信息/Info

Title:
Study on mechanism of action of Tiaogu Pian(跳骨片)medicated serum in inhibiting inflammatory reaction induced by lipopolysaccharides in chondrocytes
作者:
鄭文偉1; 何曉娟1; 賈良良1; 馬玉環(huán)1; 陳后煌1; 邵翔1; 陳達(dá)1; 劉獻(xiàn)祥1; 李西海1; 葉蕻芝2
1.福建中醫(yī)藥大學(xué),福建 福州 350122; 2.福建省中西醫(yī)結(jié)合老年性疾病重點(diǎn)實(shí)驗(yàn)室,福建 福州 350122
Author(s):
ZHENG Wenwei1; HE Xiaojuan1; JIA Liangliang1; MA Yuhuan1; CHEN Houhuang1; SHAO Xiang1; CHEN Da1; LIU Xianxiang2; LI Xihai2; YE Hongzhi1
1.Fujian University of Traditional Chinese Medicine,Fuzhou 350122,Fujian,China 2.Fujian Key Laboratory of Integrated Medicine on Geriatrics,Fuzhou 350122,Fujian,China
關(guān)鍵詞:
骨關(guān)節(jié)炎;  軟骨細(xì)胞;  跳骨片;  軟骨退變;  Wnt/β-catenin信號(hào)通路;  脂多糖類(lèi);  基質(zhì)金屬蛋白酶類(lèi);  炎癥反應(yīng);  動(dòng)物實(shí)驗(yàn)
Keywords:
Key words osteoarthritis;  chondrocytes;  Tiaogu Pian;  cartilage degeneration;  Wnt/β-catenin signaling pathway;  lipopolysaccharides;  matrix metalloproteinases;  inflammatory reaction;  animal experimentation
摘要:
目的:探討跳骨片含藥血清抑制脂多糖誘導(dǎo)的軟骨細(xì)胞炎癥反應(yīng)的作用機(jī)制。方法:將10只8周齡雄性SD大鼠隨機(jī)分為跳骨片組和空白組,跳骨片組以0.32 g·kg-1劑量的跳骨片灌胃,空白組給予等量生理鹽水灌胃; 每天灌胃1次,連續(xù)7 d; 末次灌胃1 h后,經(jīng)腹主動(dòng)脈取血,分別制備跳骨片含藥血清和空白血清,低溫保存?zhèn)溆谩?0只4周齡SD大鼠膝關(guān)節(jié)軟骨中分離軟骨細(xì)胞并培養(yǎng),光學(xué)顯微鏡下觀察軟骨細(xì)胞形態(tài),并用Ⅱ型膠原酶免疫組化鑒定。將培養(yǎng)好的第2代軟骨細(xì)胞隨機(jī)分為空白血清組、模型組、跳骨片含藥血清組,其中空白血清組以含10%空白血清的培養(yǎng)基(dulbecco modified eagle medium,DMEM)培養(yǎng); 模型組以濃度為10 ng·mL-1的脂多糖和含10%空白血清的DMEM培養(yǎng); 跳骨片含藥血清組以濃度為10 ng·mL-1的脂多糖和含10%跳骨片含藥血清的DMEM培養(yǎng); 3組均連續(xù)干預(yù)培養(yǎng)8 h,采用酶聯(lián)免疫吸附法檢測(cè)軟骨細(xì)胞基質(zhì)金屬蛋白酶(matrix metalloproteinase,MMP)3、MMP9含量,采用熒光定量RT-PCR法檢測(cè)軟骨細(xì)胞中Wnt/β-catenin信號(hào)通路相關(guān)基因表達(dá)水平,采用Western blot法檢測(cè)軟骨細(xì)胞中β-鏈蛋白(β-catenin)、卷曲蛋白-2(Frizzled-2)的蛋白表達(dá)量,采用免疫熒光檢測(cè)法檢測(cè)軟骨細(xì)胞中β-catenin、糖原合成酶激酶-3β(glycogen synthasc kinase-3β,GSK-3β)、蛋白多糖1(proteoglycans 1,PGS1)的蛋白表達(dá)量。結(jié)果:①軟骨細(xì)胞免疫組化鑒定結(jié)果。第2代軟骨細(xì)胞胞漿及細(xì)胞膜呈棕黃色陽(yáng)性染色,具有典型的軟骨細(xì)胞生物學(xué)特征。②軟骨細(xì)胞MMP3、MMP9含量。脂多糖干預(yù)8 h后,空白血清組、模型組和跳骨片含藥血清組的軟骨細(xì)胞MMP3、MMP9含量比較,組間差異均有統(tǒng)計(jì)學(xué)意義[(34.019±1.036)ng·mL-1,(44.645±2.473)ng·mL-1,(32.941±1.792)ng·mL-1,F=36.060,P=0.000;(1.348±0.038)ng·mL-1,(1.562±0.112)ng·mL-1,(1.331±0.015)ng·mL-1,F=11.319,P=0.000]; 模型組軟骨細(xì)胞MMP3、MMP9含量均高于空白血清組(LSD-t=-7.016,P=0.000; LSD-t=-3.768,P=0.003); 跳骨片含藥血清組軟骨細(xì)胞MMP3、MMP9含量均低于模型組(LSD-t=7.652,P=0.000; LSD-t=4.066,P=0.002); 空白血清組軟骨細(xì)胞MMP3、MMP9含量與跳骨片含藥血清組比較,差異均無(wú)統(tǒng)計(jì)意義(LSD-t=0.635,P=0.549; LSD-t=0.299,P=0.770)。③軟骨細(xì)胞中Wnt/β-catenin信號(hào)通路相關(guān)基因的表達(dá)。脂多糖干預(yù)8 h后,空白血清組、模型組和跳骨片含藥血清組軟骨細(xì)胞中β-catenin、GSK-3β、Frizzled-2、Wnt-4、CKI-ε基因表達(dá)量比較,組間差異均有統(tǒng)計(jì)學(xué)意義(1.000±0.275,2.258±0.206,1.431±0.304,F=36.709,P=0.000; 1.000±0.133,0.417±0.104,0.842±0.094,F=29.259,P=0.000; 1.000±0.191,1.737±0.238,1.445±0.337,F=7.027,P=0.015; 1.000±0.341,3.801±0.579,1.876±0.388,F=71.903,P=0.000; 1.000±0.309,2.208±0.708,1.441±0.421,F=64.178,P=0.000); 模型組軟骨細(xì)胞中β-catenin、Frizzled-2、Wnt-4、CKI-ε基因表達(dá)量均高于空白血清組(LSD-t=-8.431,P=0.000; LSD-t=-3.723,P=0.005; LSD-t=8.062,P=0.000; LSD-t=-11.235,P=0.000),GSK-3β基因表達(dá)量低于空白血清組(LSD-t=7.397,P=0.000); 跳骨片含藥血清組軟骨細(xì)胞中β-catenin、Frizzled-2、Wnt-4、CKI-ε基因表達(dá)量均低于模型組(LSD-t=5.541,P=0.000; LSD-t=1.477,P=0.017; LSD-t=8.062,P=0.000; LSD-t=6.882,P=0.000),GSK-3β基因表達(dá)量高于模型組(LSD-t=-5.387,P=0.000); 空白血清組軟骨細(xì)胞中β-catenin、Wnt-4、CKI-ε基因表達(dá)量均低于跳骨片含藥血清組(LSD-t=-2.289,P=0.018; LSD-t=-3.658,P=0.005; LSD-t=-4.352,P=0.002); 空白血清組軟骨細(xì)胞中GSK-3β、Frizzled-2基因表達(dá)量與跳骨片含藥血清組比較,差異均無(wú)統(tǒng)計(jì)學(xué)意義(LSD-t=2.009,P=0.075; LSD-t=-3.658,P=0.051)。④軟骨細(xì)胞中β-catenin、Frizzled-2的蛋白表達(dá)。脂多糖干預(yù)8 h后,空白血清組、模型組和跳骨片含藥血清組軟骨細(xì)胞中β-catenin、Frizzled-2蛋白表達(dá)量比較,組間差異均有統(tǒng)計(jì)學(xué)意義(0.449±0.063,0.746±0.156,0.549±0.056,F=5.323,P=0.026; 1.348±0.038,1.562±0.112,1.331±0.015,F=6.291,P=0.034); 模型組軟骨細(xì)胞中β-catenin、Frizzled-2蛋白表達(dá)量高于空白血清組(LSD-t=-11.235,P=0.005; LSD-t=-3.104,P=0.021); 跳骨片含藥血清組軟骨細(xì)胞中β-catenin、Frizzled-2蛋白表達(dá)量低于模型組(LSD-t=6.883,P=0.037; LSD-t=3.039,P=0.023); 空白----------------------------------------------- 血清組軟骨細(xì)胞中β-catenin蛋白表達(dá)量低于跳骨片含藥血清組(LSD-t=-4.352,P=0.002); 空白血清組軟骨細(xì)胞中Frizzled-2蛋白表達(dá)量與跳骨片含藥血清組比較,差異無(wú)統(tǒng)計(jì)學(xué)意義(LSD-t=-0.065,P=0.950)。⑤軟骨細(xì)胞中β-catenin、GSK-3β、PGS1的蛋白表達(dá)。脂多糖干預(yù)8 h后,軟骨細(xì)胞中β-catenin、GSK-3β、PGS1蛋白染色明顯,呈綠色; 空白血清組、模型組和跳骨片含藥血清組軟骨細(xì)胞中β-catenin、GSK-3β、PGS1蛋白表達(dá)量比較,組間差異均有統(tǒng)計(jì)學(xué)意義(0.014±0.002,0.029±0.006,0.018±0.002,F=9.910,P=0.013; 0.380±0.011,0.237±0.015,0.287±0.002,F=56.639,P=0.000; 0.034±0.003,0.022±0.002,0.029±0.003,F=27.232,P=0.001); 模型組軟骨細(xì)胞β-catenin蛋白表達(dá)量高于空白血清組(LSD-t=-4.103,P=0.006),GSK-3β、PGS1蛋白表達(dá)量低于空白血清組(LSD-t=1.048,P=0.000; t=7.365,P=0.000); 跳骨片含藥血清組軟骨細(xì)胞β-catenin蛋白表達(dá)量低于模型組(LSD-t=-3.548,P=0.012),GSK-3β、PGS1蛋白表達(dá)量高于模型組(LSD-t=-3.657,P=0.011; LSD-t=-3.273,P=0.017); 空白血清組軟骨細(xì)胞中β-catenin蛋白表達(dá)量與跳骨片含藥血清組比較,差異無(wú)統(tǒng)計(jì)學(xué)意義(LSD-t=-0.554,P=0.599); 空白血清組軟骨細(xì)胞中GSK-3β、PGS1蛋白表達(dá)量高于跳骨片含藥血清組(LSD-t=6.827,P=0.000; LSD-t=4.092,P=0.010)。結(jié)論:跳骨片含藥血清可以抑制脂多糖誘導(dǎo)的軟骨細(xì)胞炎癥反應(yīng),延緩關(guān)節(jié)軟骨退變。其作用機(jī)制可能與Wnt/β-catenin信號(hào)通路的調(diào)控有關(guān),其中β-catenin、Frizzled-2、GSK-3β、Wnt-4、CKI-ε基因可能是該信號(hào)通路的重要靶點(diǎn)。但是由于引起OA的因素眾多且跳骨片含藥血清成分多且復(fù)雜,有待于進(jìn)一步研究證實(shí)。
Abstract:
ABSTRACT Objective:To explore the mechanism of action of Tiaogu Pian(跳骨片,TGP)medicated serum in inhibiting inflammatory reaction induced by lipopolysaccharides in chondrocytes.Methods:Ten 8-week-old male SD rats were randomly divided into TGP group and blank group.The rats in TGP group were intragastric administrated with TGP in dosage of 0.32 g/kg,while the others in blank group were intragastric administrated with the same dose of normal saline,once per day for 7 consecutive days.At 1 hour after the last intragastric administration,their blood were fetched out from abdominal aorta and were made into TGP medicated serum and blank serum respectively and the serum were reserved at low temperature for future use.The chondrocytes of ten 4-week-old SD rats were isolated from knee articular cartilage and were cultured.The chondrocytes morphology were observed under optical microscope,and immunohistochemical identification were carried out by using typeⅡcollagenase.The second-generation chondrocytes were randomly divided into blank serum group,model group and TGP medicated serum group.The chondrocytes in blank serum group were cultured in dulbecco modified eagle medium(DMEM)supplemented with 10% blank serum.The chondrocytes in model group were cultured in DMEM supplemented with lipopolysaccharide(LPS)with concentration of 10 ng/ml and 10% blank serum.The chondrocytes in TGP medicated serum group were cultured in DMEM supplemented with LPS with concentration of 10 ng/ml and 10% TGP medicated serum.The chondrocytes in the 3 groups were intervened and cultured for continuous 8 hours.The content of matrix metalloproteinase(MMP)3 and MMP9 in chondrocytes were detected by using enzyme-linked immunoadsordent assay(ELISA).The expression levels of gene related to Wnt/β-catenin signaling pathway in chondrocytes were detected by using fluorescence quantitative RT-PCR method.The protein expressions of β-catenin and Frizzled-2 in chondrocytes were detected by using Western blot method.The protein expressions of β-catenin,glycogen synthasc kinase-3β(GSK-3β)and proteoglycans 1(PGS1)in chondrocytes were detected by using immunofluorescence assay(IFA).Results:The second-generation chondrocytes had typical biological characteristics of chondrocytes and their endochylemas and cytomembranes presented with brown-yellow positive staining.After 8-hour intervention by LPS,there was statistical difference in the content of MMP3 and MMP9 in chondrocytes between blank serum group,model group and TGP medicated serum group(34.019+/-1.036,44.645+/-2.473,32.941+/-1.792 ng/ml,F=36.060,P=0.000; 1.348+/-0.038,1.562+/-0.112,1.331+/-0.015 ng/ml,F=11.319,P=0.000).The content of MMP3 and MMP9 in chondrocytes were higher in model group compared to blank serum group(LSD-t=-7.016,P=0.000; LSD-t=-3.768,P=0.003)and were lower in TGP medicated serum group compared to model group(LSD-t=7.652,P=0.000; LSD-t=4.066,P=0.002).There was no statistical difference in the content of MMP3 and MMP9 in chondrocytes between blank serum group and TGP medicated serum group(LSD-t=0.635,P=0.549; LSD-t=0.299,P=0.770).After 8-hour intervention by LPS,there was statistical difference in gene expression levels of β-catenin,GSK-3β,Frizzled-2,Wnt-4 and CKI-ε between blank serum group,model group and TGP medicated serum group(1.000+/-0.275,2.258+/-0.206,1.431+/-0.304,F=36.709,P=0.000; 1.000+/-0.133,0.417+/-0.104,0.842+/-0.094,F=29.259,P=0.000; 1.000+/-0.191,1.737+/-0.238,1.445+/-0.337,F=7.027,P=0.015; 1.000+/-0.341,3.801+/-0.579,1.876+/-0.388,F=71.903,P=0.000; 1.000+/-0.309,2.208+/-0.708,1.441+/-0.421,F=64.178,P=0.000).The gene expression levels of β-catenin,Frizzled-2,Wnt-4 and CKI-εin chondrocytes were higher and the gene expression levels of GSK-3βwere lower in model group compared to blank serum group(LSD-t=-8.431,P=0.000; LSD-t=-3.723,P=0.005; LSD-t=8.062,P=0.000; LSD-t=-11.235,P=0.000,LSD-t=7.397,P=0.000).The gene expression levels of β-catenin,Frizzled-2,Wnt-4 and CKI-ε in chondrocytes were lower and the gene expression levels of GSK-3β were higher in TGP medicated serum group compared to model group(LSD-t=5.541,P=0.000; LSD-t=1.477,P=0.017; LSD-t=8.062,P=0.000; LSD-t=6.882,P=0.000; LSD-t=-5.387,P=0.000).The gene expression levels of β-catenin,Wnt-4 and CKI-ε in chondrocytes were lower in blank serum group compared to TGP medicated serum group(LSD-t=-2.289,P=0.018; LSD-t=-3.658,P=0.005; LSD-t=-4.352,P=0.002).There was no statistical difference in gene expression levels of GSK-3β and Frizzled-2 between blank serum group and TGP medicated serum group(LSD-t=2.009,P=0.075; LSD-t=-3.658,P=0.051).After 8-hour intervention by LPS,there was statistical difference in protein expressions of β-catenin and Frizzled-2 between blank serum group,model group and TGP medicated serum group(0.449+/-0.063,0.746+/-0.156,0.549+/-0.056,F=5.323,P=0.026; 1.348+/-0.038; 1.562+/-0.112; 1.331+/-0.015,F=6.291,P=0.034).The protein expressions of β-catenin and Frizzled-2 in chondrocytes were higher in model group compared to blank serum group(LSD-t=-11.235,P=0.005; LSD-t=-3.104,P=0.021).The protein expressions of β-catenin and Frizzled-2 in chondrocytes were lower in TGP medicated serum group compared to model group(LSD-t=6.883,P=0.037; LSD-t=3.039,P=0.023).The protein expressions of β-catenin in chondrocytes were lower in blank serum group compared to TGP medicated serum group(LSD-t=-4.352,P=0.002).There was no statistical difference in protein expressions of Frizzled-2 between blank serum group and TGP medicated serum group(LSD-t=-0.065,P=0.950).After 8-hour intervention by LPS,the chondrocytes presented with obvious green staining of β-catenin,GSK-3β and PGS1 protein.There was statistical difference in protein expressions of β-catenin,GSK-3β and PGS1 between blank serum group,model group and TGP medicated serum group(0.014+/-0.002,0.029+/-0.006,0.018+/-0.002,F=9.910,P=0.013; 0.380+/-0.011,0.237+/-0.015,0.287+/-0.002,F=56.639,P=0.000; 0.034+/-0.003,0.022+/-0.002,0.029+/-0.003,F=27.232,P=0.001).The protein expressions of β-catenin were higher and the protein expressions of GSK-3β and PGS1 were lower in model group compared to blank serum group(LSD-t=-4.103,P=0.006; LSD-t=1.048,P=0.000; t=7.365,P=0.000).The protein expressions of β-catenin were lower and the protein expressions of GSK-3β and PGS1 were higher in TGP medicated serum group compared to model group(LSD-t=-3.548,P=0.012; LSD-t=-3.657,P=0.011; LSD-t=-3.273,P=0.017).There was no statistical difference in protein expressions of β-catenin between blank serum group and TGP medicated serum group(LSD-t=-0.554,P=0.599).The protein expressions of GSK-3βand PGS1 were higher in blank serum group compared to TGP medicated serum group(LSD-t=6.827,P=0.000; LSD-t=4.092,P=0.010).Conclusion:TGP medicated serum can inhibit inflammatory reaction induced by LPS in chondrocytes and delay the articular cartilage degeneration.The mechanisms of action may be related to the regulation of Wnt/β-catenin signaling pathway,in which β-catenin gene,Frizzled-2 gene,GSK-3β gene,Wnt-4 gene and CKI-ε gene may be the important action targets.However,many factors can cause OA and there are many complicated ingredients in TGP medicated serum,further studies are needed to confirm the specific action targets.

參考文獻(xiàn)/References:

[1] MALAISE O,RELIC B,QUESADA-CALVO F,et al.Selective glucocorticoid receptor modulator compound A,in contrast to prednisolone, does not induce leptin or the leptin receptor in human osteoarthritis synovial fibroblasts[J].Rheumatology(Oxford),2015,54(6):1087-1092.
[2] ROCKEL JS,YU C,WHETSTONE H,et al.Hedgehog inhibits β-catenin activity in synovial joint development and osteoarthritis[J].J Clin Invest,2016,126(5):1649-1663.
[3] BOUAZIZ W,SIGAUX J,MODROWSKI D,et al.Interaction of HIF1α and β-catenin inhibits matrix metalloproteinase 13 expression and prevents cartilage damage in mice[J].Proc Natl Acad Sci U S A,2016,113(19):5453-5458.
[4] 鄭文偉,馬玉環(huán),林平冬,等.跳骨片水提物對(duì)體外大鼠關(guān)節(jié)軟骨細(xì)胞活性的影響[J].風(fēng)濕病與關(guān)節(jié)炎,2017,6(1):5-8.
[5] 黃繼漢,黃曉暉,陳志揚(yáng),等.藥理試驗(yàn)中動(dòng)物間和動(dòng)物與人體間的等效劑量換算[J].中國(guó)臨床藥理學(xué)與治療學(xué),2004,9(9):1069-1072.
[6] CHAN CM,MACDONALD CD,LITHERLAND GJ,et al.Cytokine-induced MMP13 Expression in Human Chondrocytes Is Dependent on Activating Transcription Factor 3(ATF3)Regulation[J].J Biol Chem,2017,292(5):1625-1636.
[7] KANEKO M,TOMITA T,NAKASE T,et al.Expression of proteinases and inflammatory cytokines in subchondral bone regions in the destructive joint of rheumatoid arthritis[J].Rheumatology(Oxford),2001,40(3):247-255.
[8] SUN S,BAYJENSEN AC,KARSDAL MA,et al.The active form of MMP-3 is a marker of synovial inflammation and cartilage turnover in inflammatory joint diseases[J].BMC Musculoskelet Disord,2014,15(1):93.
[9] ÖZLER K,AKTA �瘙 塁 E,ATAY Ç, et al.Serum and knee synovial fluid matrixmetalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late stage osteoarthritis[J].Acta Orthop Traum Turc,2016,50(3):356.
[10] USAMI Y,GUNAWARDENA AT,IWAMOTO M,et al.Wnt signaling in cartilage development and diseases: lessons from animal studies[J].Lab Invest,2016,96(2):186-196.
[11] GAO ZH,SEELING JM,HILL V,et al.Casein kinase I phosphorylates and destabilizes the beta-catenin degradation complex[J].Proc Natl Acad Sci U S A,2002,99(3):1182-1187.
[12] UMAR S,WANG Y,MORRIS AP,et al.Dual alterations in casein kinase I-epsilon and GSK-3beta modulate beta-catenin stability in hyperproliferating colonic epithelia[J].Am J Physiol Gastrointest Liver Physiol,2007,292(2):G599-G607.
[13] DU G,SONG Y,WEI L,et al.Osthole inhibits proliferation and induces catabolism in rat chondrocytes and cartilage tissue[J].Cell Physiol Biochem,2015,36(6):2480-2493.
[14] 趙晉,閆振宇,張立智.骨性關(guān)節(jié)炎軟骨和軟骨下骨之間信號(hào)通路[J].中華骨質(zhì)疏松和骨礦鹽疾病雜志,2016,9(2):193-198.

相似文獻(xiàn)/References:

[1]孟維娜,明立功,王新德,等.關(guān)節(jié)鏡下清理聯(lián)合腓骨近1/3段截骨治療膝骨關(guān)節(jié)炎[J].中醫(yī)正骨,2015,27(11):40.
[2]明立功,孟維娜,王新德,等.腓骨近端截骨治療內(nèi)側(cè)間室膝骨關(guān)節(jié)炎的近期療效觀察[J].中醫(yī)正骨,2015,27(10):25.
[3]張杰,王人彥,張玉柱.膝骨關(guān)節(jié)炎的治療進(jìn)展[J].中醫(yī)正骨,2015,27(10):68.
[4]梁朝,蔡靜怡,閆立,等.針刀療法改善膝骨關(guān)節(jié)炎早期疼痛癥狀的療效評(píng)價(jià)[J].中醫(yī)正骨,2015,27(09):9.
　LIANG Zhao,CAI Jingyi,YAN Li,et al.Evaluation of the curative effect of needle-knife therapy for relieving knee pain in patients with early knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):9.
[5]王建武,黨建軍,李強(qiáng),等.四聯(lián)療法治療膝骨關(guān)節(jié)炎[J].中醫(yī)正骨,2015,27(08):44.
[6]劉紅娟,郭會(huì)利,郭樹(shù)農(nóng).云克聯(lián)合中藥治療膝骨關(guān)節(jié)炎的護(hù)理[J].中醫(yī)正骨,2015,27(08):75.
[7]陳衛(wèi)衡.探索建立系統(tǒng)的膝骨關(guān)節(jié)炎中醫(yī)臨床科研范式 和理論體系[J].中醫(yī)正骨,2015,27(07):1.
[8]鄭春松,葉蕻芝,李西海,等.透骨消痛膠囊中補(bǔ)腎柔肝藥和活血祛風(fēng)藥治療 骨關(guān)節(jié)炎作用方式的計(jì)算機(jī)模擬比較[J].中醫(yī)正骨,2015,27(07):6.
　ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Comparison of the mode of action of Bushen Rougan(補(bǔ)腎柔肝)drugs versus Huoxue Qufeng(活血祛風(fēng))drugs contained in Tougu Xiaotong Jiaonang(透骨消痛膠囊)for the treatment of osteoarthritis:A computer simulation study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):6.
[9]帥波,沈霖,楊艷萍,等.加味青娥丸治療膝骨關(guān)節(jié)炎的作用機(jī)制研究[J].中醫(yī)正骨,2015,27(07):15.
　SHUAI Bo,SHEN Lin,YANG Yanping,et al.Study on the mechanism of action of Jiawei Qing'e Wan(加味青娥丸)for the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):15.
[10]梅其杰,袁長(zhǎng)深,段戡,等.壯藥骨痹方燙熨聯(lián)合運(yùn)動(dòng)療法治療膝骨關(guān)節(jié)炎的臨床研究[J].中醫(yī)正骨,2015,27(07):27.
　MEI Qijie,YUAN Changshen,DUAN Kan,et al.Clinical study of the curative effect of hot compressing and rubbing with packet of Gubi Fang(骨痹方)combined with exercise therapy in the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):27.
[11]鄭春松,葉蕻芝,李西海,等.獨(dú)活寄生湯含藥血清對(duì)白細(xì)胞介素1β誘導(dǎo)的 退變關(guān)節(jié)軟骨細(xì)胞中基質(zhì)金屬蛋白酶 和環(huán)氧化酶2表達(dá)的影響[J].中醫(yī)正骨,2015,27(12):1.
　ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Impact of Duhuo Jisheng Tang(獨(dú)活寄生湯)medicated serum on expression of matrix metalloproteinase and cyclooxygenase 2 in degenerative articular chondrocytes induced by interleukin-1 beta[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):1.
[12]林木南,林艷紅,劉獻(xiàn)祥,等.溫?zé)崾杳懿▽?duì)膝骨關(guān)節(jié)炎模型大鼠軟骨細(xì)胞 RAS/絲裂原活化蛋白激酶信號(hào)通路的影響[J].中醫(yī)正骨,2016,28(02):1.
　LIN Munan,LIN Yanhong,LIU Xianxiang,et al.Effect of warm sparse-dense wave on RAS/mitogen-activated protein kinase signaling pathway in chondrocytes of knee osteoarthritis rat models[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(08):1.
[13]原曉強(qiáng),金王東,周云婧,等.純化血小板對(duì)大鼠軟骨細(xì)胞增殖及膝骨關(guān)節(jié)炎大鼠軟骨修復(fù)的作用研究[J].中醫(yī)正骨,2016,28(12):6.
　YUAN Xiaoqiang,JIN Wangdong,ZHOU Yunjing,et al.Effect of purified platelet rich plasma on chondrocyte proliferation in rats and cartilage repair in rats with knee osteoarthritis:an experimental study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(08):6.
[14]劉啟明,羅統(tǒng)富,董黎強(qiáng),等.植物雌激素類(lèi)中藥延緩關(guān)節(jié)軟骨細(xì)胞退變的研究進(jìn)展[J].中醫(yī)正骨,2017,29(05):27.
[15]葉錦霞,付長(zhǎng)龍,林潔,等.透骨消痛膠囊對(duì)毒胡蘿卜素誘導(dǎo)的內(nèi)質(zhì)網(wǎng)應(yīng)激PEKR信號(hào)通路介導(dǎo)的大鼠體外培養(yǎng)關(guān)節(jié)軟骨細(xì)胞凋亡的影響[J].中醫(yī)正骨,2017,29(06):1.
　YE Jinxia,FU Changlong,LIN Jie,et al.Effect of Tougu Xiaotong Jiaonang(透骨消痛膠囊)on apoptosis mediated by endoplasmic reticulum stress(PEKR signaling pathway)and induced by thapsigargin in rat's articular chondrocytes cultured in vitro[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(08):1.
[16]何曉娟,林平冬,馬玉環(huán),等.獨(dú)活寄生湯含藥血清抑制白細(xì)胞介素1β誘導(dǎo)的軟骨細(xì)胞炎癥反應(yīng)的作用機(jī)制研究[J].中醫(yī)正骨,2017,29(08):1.
　HE Xiaojuan,LIN Pingdong,MA Yuhuan,et al.Study on mechanism of action of Duhuo Jisheng Tang(獨(dú)活寄生湯)medicated serum in inhibiting inflammatory reaction induced by interleukin-1 beta in chondrocytes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(08):1.
[17]陳世宣,劉益杰,胡笑燊,等.基于瞬時(shí)受體電位香草素亞家族4信號(hào)通路探討牛蒡子苷元對(duì)體外培養(yǎng)軟骨細(xì)胞增殖及Ⅱ型膠原蛋白和軟骨蛋白聚糖表達(dá)的影響[J].中醫(yī)正骨,2017,29(10):13.
　CHEN Shixuan,LIU Yijie,HU Xiaoshen,et al.An experimental study of effect of arctigenin on proliferation of chondrocyte cultured in vitro and expression of typeⅡcollagen protein and aggrecan based on the transient receptor potential vanilloid 4 signaling pathway[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(08):13.
[18]陳俊,吳廣文,許惠鳳,等.獨(dú)活寄生湯含藥血清對(duì)大鼠退變軟骨細(xì)胞蛋白激酶 R樣內(nèi)質(zhì)網(wǎng)激酶/免疫球蛋白結(jié)合蛋白信號(hào)通路的影響[J].中醫(yī)正骨,2018,30(08):1.
　CHEN Jun,WU Guangwen,XU Huifeng,et al.Effect of Duhuo Jisheng Tang(獨(dú)活寄生湯)medicated serum on protein kinase R-like endoplasmic reticulum kinase/immunoglobulin-binding protein signaling pathway in degenerated chondrocytes of rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(08):1.
[19]許麗梅,李慧,許云騰,等.基于NF-κB信號(hào)通路探討?yīng)毣罴纳鷾种浦嗵钦T導(dǎo)的軟骨細(xì)胞炎癥反應(yīng)的作用機(jī)制[J].中醫(yī)正骨,2019,31(07):9.
　XU Limei,LI Hui,XU Yunteng,et al.An experimental study of mechanism of action of Duhuo Jisheng Tang(獨(dú)活寄生湯)in inhibiting inflammatory reaction induced by lipopolysaccharide in chondrocytes based on NF-κB signaling pathway[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(08):9.
[20]王會(huì)含,王永堂,苗建華,等.川芎嗪對(duì)人骨關(guān)節(jié)炎軟骨細(xì)胞的影響及作用機(jī)制研究[J].中醫(yī)正骨,2021,33(07):4.
　WANG Huihan,WANG Yongtang,MIAO Jianhua,et al.A study of the effects of tetramethylpyrazine on human osteoarthritic chondrocytes and its mechanism of action[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(08):4.

備注/Memo

備注/Memo:
基金項(xiàng)目:福建省科學(xué)技術(shù)廳重點(diǎn)資助項(xiàng)目(2014Y0064) 通訊作者:葉蕻芝 E-mail:[email protected]
更新日期/Last Update: 2017-12-29